Electrocardiographic holter recorders and analysis software according to the models detailed below ישראל - עברית - Ministry of Health

electrocardiographic holter recorders and analysis software according to the models detailed below

אלדן ציוד אלקטרוני בע"מ - צוות טכני - מיכשור ותוכנות לאבחון קרדיולוגי

Respiratory Therapy Devices (as detailed in Appendix 1) ישראל - עברית - Ministry of Health

respiratory therapy devices (as detailed in appendix 1)

ע.י. מדיקוויפ - רופא - המוצר מיועד למרפאות הקהילה לחולים עם בעיות בנשימה ,בבית או בבית אבות או במוסדות אחרים שנדרשת להם עזרה בהנשמה

אתופן 400 ישראל - עברית - Ministry of Health

אתופן 400

taro pharmaceutical industries ltd - etodolac - טבליה - etodolac 400 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.

אתופן 200 ישראל - עברית - Ministry of Health

אתופן 200

taro pharmaceutical industries ltd - etodolac - קפסולות - etodolac 200 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.

אתופן 300 ישראל - עברית - Ministry of Health

אתופן 300

taro pharmaceutical industries ltd - etodolac - קפסולות - etodolac 300 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.

אתופן 500 ישראל - עברית - Ministry of Health

אתופן 500

taro pharmaceutical industries ltd - etodolac - טבליה - etodolac 500 mg - etodolac - etodolac - for the managament of signs and symptoms of osteoarthritis and rheumatoid arthritis.for the management of pain.

אתופן XL 600 ישראל - עברית - Ministry of Health

אתופן xl 600

taro pharmaceutical industries ltd - etodolac - טבליות עם שחרור נרחב - etodolac 600 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis.

אתופן XL 400 ישראל - עברית - Ministry of Health

אתופן xl 400

taro pharmaceutical industries ltd - etodolac - טבליות עם שחרור נרחב - etodolac 400 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthrities and rheumatoid arthritis.

בינוקריט 1000 יחבל 0.5 מל ישראל - עברית - Ministry of Health

בינוקריט 1000 יחבל 0.5 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

בינוקריט 2000 יחבל 1 מל ישראל - עברית - Ministry of Health

בינוקריט 2000 יחבל 1 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob